摘要
目的:了解我院口服降糖药使用现状及发展趋势,促进临床合理用药。方法:对我院2007-2009年口服降糖药的销售金额、用药频度(DDDs)、日均费用(DDC)等进行回顾性分析。结果:我院2007-2009年口服降糖药销售金额呈上升趋势,销售金额排在前三位的是阿卡波糖、盐酸二甲双胍片、格列美脲;DDDs排序前三位的是阿卡波糖、盐酸二甲双胍片、格列喹酮。结论:我院口服降糖药应用基本合理,新药用量呈上升趋势,高效、安全、依从性好的药物临床应用广泛。
Objective:To investigate the status quo and the development trend of the utilization of oral hypoglycemic drugs in our hospital so as to improve rational drug use.Methods:The utilization of oral hypoglycemic drugs from 2007 to 2009 was analyzed in respect of consumption sum,DDDs and average daily cost.Results:The consumption sum of oral hypoglycemic drugs has increased over the three years.Acarbose,metformin and glimepiride ranked the top 3 in respect of consumption sum,and acarbose,metformin and gliquidone dominated the top 3 in respect of DDDs.Conclusion:The utilization of oral hypoglycemic drugs in our hospital was basically rational,and drugs with good effectiveness,safety and tolerability were widely used in clinic.
出处
《中国药物应用与监测》
CAS
2010年第5期295-296,共2页
Chinese Journal of Drug Application and Monitoring